On March 27, medical device manufacturer Arrow International
- Total revenue jumped by 7.7% to $125.5 million on the back of sales growth of 9.2% for central venous catheters and 8.5% for specialty catheters.
- Net profit rose by 14.5% on account of increased revenue and improved margins.
- For 2007, net sales are targeted in the range of $515 million to $525 million, with EPS of $1.40 to $1.48.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q2 2006 |
Q2 2005 |
Change |
|
|---|---|---|---|
|
Sales |
$125.5 |
$116.5 |
7.7% |
|
Net Profit |
$14.5 |
$12.6 |
14.5% |
|
EPS |
$0.32 |
$0.28 |
14.3% |
|
Diluted Shares |
45.6 |
45.3 |
0.8% |
Get back to basics with the income statement.
Margin Checkup
|
Q2 2006 |
Q2 2005 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
50.5% |
48.7% |
1.7 |
|
Operating Margin |
17.2% |
15.5% |
1.6 |
|
Net Margin |
11.5% |
10.8% |
0.7 |
Margins are the earnings engine.
Balance Sheet Highlights
|
Assets |
Q2 2006 |
Q2 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$172.7 |
$122.9 |
40.6% |
|
Accounts Rec. |
$102.8 |
$90.7 |
13.3% |
|
Inventory |
$107.3 |
$102.6 |
4.6% |
The balance sheet reflects the company's health.
Cash Flow Highlights
A statement of cash flows was not provided. Boo!
Free cash flow is a Fool's best friend.
Related Foolishness:
Think you can pitch your favorite stock -- or ditch your least favorite one -- in 27 seconds or less? That's just what we're doing over at Motley Fool CAPS! Check out our new 27-second stock pitches.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
